Skip to main content
Screener/Healthcare/Biotechnology

ARVN — Arvinas, Inc.

NASDAQ
$10.55+0.66 (+6.62%)
Small CapUnder $20HealthcareHigh Beta
$5.90
$14.51
$9.73
$11.40
EPS (TTM)$-1.22
P/E Ratio-8.21
Dividend Yield—
Market Cap$669.2M
Volume1.70M
Prev Close$9.90
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$9.5M-$67.4M$-1.0487.4%-709.5%
Q3 '25$41.9M-$35.1M$-0.48100.0%-83.8%
Q2 '25$22.4M-$61.2M$-0.84100.0%-273.2%
Q1 '25$188.8M$82.9M$1.14100.0%43.9%
Q4 '24$59.2M-$45.1M$-0.63100.0%-76.2%
Q3 '24$102.4M-$49.2M$-0.68100.0%-48.0%
Q2 '24$76.5M-$35.2M$-0.4997.8%-46.0%
Q1 '24$25.3M-$69.4M$-0.9793.3%-274.3%
Get Your Daily Market Recap